| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.580 | 44.593 | 44.730 | 73.274 | 71.684 | 69.056 | 144.852 | 189.440 | 262.527 | 285.844 |
| Total Income - EUR | 41.657 | 44.596 | 44.732 | 77.272 | 71.813 | 69.873 | 145.136 | 189.503 | 262.622 | 286.042 |
| Total Expenses - EUR | 34.473 | 39.732 | 37.573 | 50.005 | 69.441 | 73.909 | 97.641 | 116.797 | 167.385 | 175.076 |
| Gross Profit/Loss - EUR | 7.184 | 4.864 | 7.159 | 27.267 | 2.372 | -4.037 | 47.495 | 72.706 | 95.237 | 110.966 |
| Net Profit/Loss - EUR | 5.937 | 3.973 | 5.912 | 26.494 | 1.656 | -4.677 | 46.073 | 70.849 | 92.663 | 102.562 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Ra Fiziomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.549 | 4.005 | 17.443 | 38.800 | 31.757 | 95.290 | 85.076 | 68.633 | 485.598 | 477.597 |
| Current Assets | 7.988 | 6.414 | 27.343 | 27.806 | 6.865 | 5.974 | 11.241 | 25.601 | 32.273 | 11.922 |
| Inventories | 103 | 548 | 0 | 0 | 0 | 1.363 | 0 | 0 | 0 | 0 |
| Receivables | 415 | 537 | 3.537 | 1.680 | 2.756 | 3.771 | 3.434 | 11.467 | 19.471 | 1.525 |
| Cash | 7.469 | 5.330 | 23.807 | 26.127 | 4.109 | 840 | 7.807 | 14.134 | 12.802 | 10.397 |
| Shareholders Funds | 7.780 | 4.026 | 5.964 | 26.430 | 1.764 | -3.142 | 42.973 | 70.065 | 92.760 | 102.612 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 8.825 | 6.394 | 38.864 | 40.177 | 36.858 | 104.406 | 53.351 | 24.360 | 425.966 | 387.911 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ra Fiziomed S.r.l.